We are live on ! Find out more
ACER

Acer Therapeutics Inc

Delisted

ACER was delisted on the 8th of November, 2023.

34 hedge funds and large institutions have $6.86M invested in Acer Therapeutics Inc in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more capital invested

Capital invested by funds: $4.59M → $6.86M (+$2.27M)

8% less funds holding

Funds holding: 3734 (-3)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

71% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 17

Holders
34
Holders Change
-3
Holders Change %
-8.11%
% of All Funds
0.7%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
5
Reduced
17
Closed
11
Calls
Puts
Net Calls
Net Calls Change

ACER Hedge Fund Activity: Q2 2020 in Review

34 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2020, worth a combined $6.86M — up 49% from $4.59M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ACER and 8 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 5 added.

The largest buyer was Worth Venture Partners, opening a new position worth an estimated $448K. The largest seller was BlackRock, cutting an estimated $629K.

  • 34 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2020, down from 37 in Q1 2020.
  • Funds reported $6.86M of Acer Therapeutics Inc stock for Q2 2020, up 49% quarter-over-quarter.
  • 8 funds opened new Acer Therapeutics Inc positions in Q2 2020 and 11 closed out, a net change of -3 holders.
  • The largest Acer Therapeutics Inc buyer in Q2 2020 was Worth Venture Partners, an estimated $448K added.
  • The largest Acer Therapeutics Inc seller in Q2 2020 was BlackRock, an estimated $629K sold.

Based on aggregated 13F filings for Q2 2020.